MODERN DIAGNOSTICS OF JUVENILE RHEUMATOID ARTHRITIS IN CHILDREN
Abstract
Juvenile Rheumatoid Arthritis (JRA), currently referred to as Juvenile Idiopathic Arthritis (JIA), represents a heterogeneous group of chronic inflammatory joint diseases occurring in children under the age of 16. Early diagnosis remains a clinical challenge due to the variability of symptoms and lack of a single definitive diagnostic test. Modern diagnostic approaches combine clinical evaluation, laboratory markers, imaging modalities, and emerging biomarkers. This article reviews current advances in the diagnosis of JIA and highlights the importance of early detection for improving long-term outcomes.
References
1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis. J Rheumatol. 2004.
2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007.
3. McQueen FM, Ostergaard M, Peterfy CG, et al. Magnetic resonance imaging in rheumatoid arthritis. Ann Rheum Dis. 2005.
4. Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for clinical inactive disease in JIA. Arthritis Care Res. 2011.
5. De Benedetti F, Schneider R. Systemic juvenile idiopathic arthritis. Lancet. 2018.
6. Foell D, Wittkowski H, Roth J. Monitoring disease activity by S100 proteins in JIA. Arthritis Rheum. 2004.
7. Ringold S, Weiss PF, Beukelman T, et al. 2019 ACR guidelines for JIA treatment. Arthritis Rheumatol. 2019.
8. Martini A. It is time to rethink juvenile idiopathic arthritis classification. Ann Rheum Dis. 2012.
